BrainStorm Cell

BrainStorm CellBrainStorm Cell
BrainStorm Cell

BrainStorm Cell

Developing innovative autologous stem cell therapies for debilitating neurodegenerative disorders like ALS, MS, and Parkinson's disease.

DR 472006Active30Petah Tikva, Israel
Rate

About

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) is a biotechnology company focused on the development and commercialization of innovative autologous stem cell therapies. Their lead product, NurOwn, is designed to treat highly debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Parkinson’s disease, which currently have limited treatment options.
Frequently asked

What does BrainStorm Cell do?

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) is a biotechnology company focused on the development and commercialization of innovative autologous stem cell therapies. Their lead product, NurOwn, is designed to treat highly debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Parkinson’s disease, which currently have limited treatment options.

What is BrainStorm Cell's revenue?

StartupHub estimates BrainStorm Cell's annual revenue at $4.8M (range $2.9M to $8.0M, 64% confidence), based on comparable companies in the sector.

Where is BrainStorm Cell headquartered?

BrainStorm Cell is headquartered in Petah Tikva, Israel.

When was BrainStorm Cell founded?

BrainStorm Cell was founded in 2006.

What industry does BrainStorm Cell operate in?

BrainStorm Cell operates in Life Sciences, Biotech, MedTech, Neurodegenerative Disorders, Stem Cell Therapy, ALS Treatment.

How many employees does BrainStorm Cell have?

BrainStorm Cell has approximately 30 people on record.

HEADCOUNT
30
DOMAIN RATING
47
Comments
(6)
4 positive2 mixed0 negative
Reddit
r/Quantisnowu/QuantisnowJun 2, 2026Positive💎

BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine.

View on Reddit
Reddit
r/edgar_newsu/edgar_news_01May 28, 2026Positive

Brainstorm Cell Therapeutics Inc. The company increased its board to eight directors and appointed Peter Pitts. Mr. Pitts was granted options to purchase 150,000 shares, with half vesting immediately and the remainder in six months.

View on Reddit
Reddit
r/Quantisnowu/QuantisnowMay 28, 2026Positive

BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors.

View on Reddit
Reddit
r/Quantisnowu/QuantisnowMay 19, 2026Positive

BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market.

View on Reddit
Reddit
r/Quantisnowu/QuantisnowMay 15, 2026Mixed

BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update.

View on Reddit
Reddit
r/Quantisnowu/QuantisnowMar 31, 2026Mixed

BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update.

View on Reddit

Some comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.